Company Overview of Actavis UK Ltd
Actavis UK Ltd develops, manufactures, and distributes generic, branded, and biosimilar pharmaceutical products. It offers alenvona and cleosensa tablets, neotigason tablets, paracetamol solutions (for infusion), over-the-counter products, and fentanyl transdermal patch solutions. The company provides its products for the treatment of diseases in central nervous system, gastroenterology, women's health, urology, cardiovascular, respiratory, and anti-infective therapeutic categories. It serves patients and healthcare professionals worldwide. The company was founded in 1903 and is based in Barnstaple, United Kingdom with manufacturing and distribution facilities in the United Kingdom and inter...
Barnstaple, EX32 8NS
Founded in 1903
Key Executives for Actavis UK Ltd
Executive Director of Finance & Information Technology
Managing Director of Operations
Executive Director of Human Resources
Vice President of UK & Ireland
Executive Director of Hospitals & Brands and Director
Compensation as of Fiscal Year 2015.
Actavis UK Ltd Key Developments
Actavis UK Wins GBP 12.4 Million Multiple Awardees Contract for Supplying Analgesic, Anaesthetic, Musculoskeletal and Joint Disease Medicines
Jan 10 16
Actavis UK Ltd., Barnstaple, won a GBP 12.4 million (excluding VAT) multiple awardees contract award from The Common Services Agency (more commonly known as NHS National Services Scotland) for the supply of a range of analgesic, anaesthetic, musculoskeletal and joint disease medicines (Oxycodone Modified and Prolonged Release Tablets). This Framework Agreement is for the supply of a range of Analgesic, Anaesthetic, Musculoskeletal and Joint Disease Medicines to NHS Scotland.
Actavis UK Ltd. Wins GBP 162.3 Million Multiple Awardees Contract
Dec 8 15
Actavis UK Ltd. won a GBP 162.3 million (excluding VAT) multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for branded pharmaceuticals (Contract Award Notice No.: 2015/S 237-430145).
Actavis UK Ltd. Wins GBP 11.2 Million Multiple Awardees Contract for Supplying Psychiatry Medicines
Aug 24 15
Actavis UK Ltd. won a GBP 11.2 million multiple awardees contract award from The Common Services Agency (more commonly known as NHS National Services Scotland) for the supply of psychiatry medicines (Lamotrigine presentations) (Contract Award Notice No.: 2015/S 162-296520; Lot No.: 2).
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|